Two genetic mutations in liver cells may drive tumor formation in intrahepatic cholangiocarcinoma (iCCA), the second most common form of liver cancer, according to a research published in the July issue of the journal Nature. (sciencedaily.com)
Upregulation of retinoic acid receptor - ß reverses drug resistance in cholangiocarcinoma cells by enhancing susceptibility to apoptosis. (abcam.com)
It is also a significant risk factor for Cholangiocarcinoma (CCA) or bile duct cancer. (sciencedaily.com)